The MMEDS Act would create tax credits for medical manufacturers that operate in economically distressed zones and for domestic manufacturers that buy eligible products or services made or provided in those zones. It would also provide higher credit rates for certain facilities that move production from abroad or make designated population health products. The bill would expand federal support for developing and distributing products intended to protect at-risk groups during epidemics and pandemics. It would define distressed zones using poverty and economic conditions, and allow some zones to be designated through an application by a state or local government.
Manufacturers could qualify for tax credits if they meet the bill’s requirements. The bill also directs federal agencies to work together to distribute approved population health products promptly to vulnerable groups. It does not guarantee that a specific company, community, or person will benefit.
The bill would reduce taxes for eligible businesses through tax credits and, for some facilities, an option to expense certain property costs. The bill text does not provide an estimate of the total cost. No publicly available information.
The bill’s stated aim is to support domestic medical manufacturing in economically distressed areas and strengthen supply chains. It also aims to encourage development and timely distribution of products that could help protect vulnerable groups during epidemics and pandemics.
No publicly available information.